Aberdeen Group
ADRX icon

Aberdeen Group’s ADARx Pharmaceuticals, Inc. Common Stock ADRX Stock Holding History

Aberdeen Group’s Portfolio ADRX Stock Details ADRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.39M Buy
+120,000
New +$2.4M ﹤0.01% 833

Other funds holding ADRX

Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return

Aberdeen Group's ADRX Position: Q3 2026 in Review

Aberdeen Group opened a new position in ADARx Pharmaceuticals, Inc. Common Stock (ADRX) in Q3 2026: 120,000 shares worth $2.39M. The stake represents ﹤0.01% of the portfolio and ranks #833 among its holdings.

2 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Aberdeen Group held 120,000 shares of ADARx Pharmaceuticals, Inc. Common Stock worth $2.39M as of Q3 2026.
  • ADARx Pharmaceuticals, Inc. Common Stock was a new Aberdeen Group position in Q3 2026.
  • ADARx Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Aberdeen Group's portfolio in Q3 2026, its #833 holding.
  • 2 funds tracked by Wall St. Rank held ADARx Pharmaceuticals, Inc. Common Stock as of Q3 2026.

Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.